Dyadic Receives U.S. Patent for Manufacturing Seasonal and Pandemic Influenza Vaccines from its Proprietary C1 Protein Production Platform JUPITER, Fla., April 18, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...

ASLAN Pharmaceuticals Acquires Full Global Commercial Rights for ASLAN004 From CSL - Amending their previous agreement, CSL grants ASLAN full global rights to develop, manufacture and commercialise ASLAN004 SINGAPORE, May 31, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals...

Omni-ID and Convergence Systems Limited Sign Global Distribution Agreement FOSTER CITY, CA--(Marketwire - May 18, 2009) - News Facts: Omni-ID, a leading innovator in passive ultra high frequency (UHF) radio frequency identification (RFID) technology, and RFID technology...